GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (FRA:1KA) » Definitions » Price-to-Funds-From-Operations

GH Research (FRA:1KA) Price-to-Funds-From-Operations : (As of Jun. 08, 2024)


View and export this data going back to 2021. Start your Free Trial

What is GH Research Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


GH Research (FRA:1KA) Business Description

Industry
Traded in Other Exchanges
Address
28 Baggot Street Lower, Dublin, IRL, D02 NX43
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.